The 8k was submitted for a Phase II trial regarding locaserin hydrochloride as a potential aid to smoking cessation.
This could be a nice ace in the hole for Arena and Eisai. 12 week double-blind trial with 600 patients. Just a small percentage of the roughly $100 billion annual spend would make Belviq a multi-billion dollar drug.